Clinical significance of anti-glomerular basement membrane antibodies in a cohort of Chinese patients with lupus nephritis

Scandinavian Journal of Rheumatology

Volumn 35, Issue 3, 2006, Pages 201-208

  Li, C H ^a,c   Li, Y C ^b   Xu, P S ^c   Hu, X ^d   Wang, C Y ^b   Zou, G L ^a  

^a WUHAN UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d HUAIHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASEMENT MEMBRANE ANTIBODY; DOUBLE STRANDED DNA; NUCLEOSOME ANTIBODY;

ADULT; ANEMIA; ANTIBODY DETECTION; ARTICLE; CHINESE; DATA COLLECTION METHOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; GOODPASTURE SYNDROME; HOSPITALIZATION; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY TEST; LUNG HEMORRHAGE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PATHOGENESIS; PLEURISY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINUSITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES; ASIAN CONTINENTAL ANCESTRY GROUP; DNA; FEMALE; HUMANS; KIDNEY; LUPUS NEPHRITIS; MALE; NUCLEOSOMES; REMISSION INDUCTION; RETROSPECTIVE STUDIES;

EID: 33745130391     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740500303181     Document Type: Article

References (36)

1. Rutgers A, Heeringa P, Damoiseaux JG, Cohen Tervaert JW. ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease. Eur J Int Med 2003;14:287-95.
2. Gallagher H, Kwan JTC, Jayne DRW. Pulmonary renal syndrome: a 4-year, single-center experience. Am J Kidney Dis 2002;39:42-7.
3. Kluth DC, Rees AJ. Anti-glomerular basement membrane disease. J Am Soc Nephrol 1999;10:2446-53.
4. Harrity P, Gilbert-Barness E, Cabalka A, Hong R, Zimmerman J. Isolated pulmonary Goodpasture syndrome. Pediatr Pathol 1991;11:635-46.
5. Wanten GJA, Koolen MI, Harthoorn-Lasthuizen EJ, Van Liebergen FJHM, Haverman JF, Assmann KJM. Antineutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in a patient with anti-glomerular basement membrane disease. Neth J Med 1995;47:25-9.
6. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
7. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:63-40.
8. Dooley MA, Aranow C, Ginzler EM. Review of ACR renal criteria in systemic lupus erythematosus. Lupus 2004;13:857-60.
9. Churg J, Sobin LH. Renal disease: classification and atlas of glomerular disease. Tokyo: Igaku-Shoin, 1982.
10. Churg J, Bernstein J, Glassock RJ. Renal disease: classification and atlas of glomerular disease, 2nd edn. New York: Igaku-Shoin, 1995.
11. Akagi S, Ichikawa H, Suzuki J, Makino H. Systemic lupus erythematosus associated with cytomegalovirus infection. Scand J Rheumatol 2004;33:58-9.
12. Berden JH. Lupus nephritis. Kidney Int 1997;52:538-58.
13. Bernstein KA, Valerio RD, Lefkowith JB. Glomerular binding activity in MRL lpr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex. J Immunol 1995;154:2424-33.
14. Hylkema MN, Van Bruggen MCJ, Van de Lagemaat R, Kramers K, Berden JHM, Smeenk RJT. Heparan sulfate staining of the glomerular basement membrane in relation to circulating anti-DNA and anti-heparan sulfate reactivity: a longitudinal study in NZB/W F1 mice. J Autoimmun 1996;9:41-50.
15. Renaudineau Y, Révélen R, Dueymes M, Levy Y, Youinou P. Autoantibodies to heparan sulfate proteoglycans. Autoimmun Rev 2002;1:305-12.
16. Termaat RM, Brinkman K, Nossent JC, Swaak AJG, Smeenk RJT, Berden JHM. Anti-heparan sulfate reactivity in sera from patients with systemic lupus erythematosus. Autoimmunity 1991;82:268.
17. Lefkowith JB, Kiehl M, Rubenstein J, Valerio RD, Bernstein K, Kahl L, et al. Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus. J Clin Invest 1996;98:1373-80.
18. Morioka T, Woitas R, Fujigaki Y, Batsford SR, Vogt A. Histone mediates glomerular deposition of small size DNA anti-DNA complex. Kidney Int 1994;45:991-7.
19. Lefkowith JB, Gilkeson GS. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum 1996;39:894-903.
20. Ghirardello A, Doria A, Zampieri S, Tarricone E, Tozzoli R, Villalta D, et al. Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. J Autoimmun 2004;22:235-40.
21. Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993;177:1367-81.
22. Van Bruggen MCJ, Kramers C, Hylkema MN, Smeenk RJT, Berden JHM. Significance of antinuclear and anti-extracellular matrix autoantibodies for albuminuria in murine lupus nephritis; a longitudinal study on plasma and glomerular eluates in MRL/l mice. Clin Exp Immunol 1996;105:132-9.
23. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1241-50.
24. Emlen W, Neibur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994;152:3685-92.
25. Tax WJ, Kramers C, Van Bruggen MC, Berden JH. Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus. Kidney Int 1995;48:666-73.
26. Benucci M, Gobbi FL, Del Rosso A, Cesaretti S, Niccoli L, Cantini F. Disease activity and antinucleosome antibodies in systemic lupus erythematosus. Scand J Rheumatol 2003;32:42-5.
27. Burlingame RW. Recent advances in understanding the clinical utility and underlying cause of antinucleosome (antichromatin) autoantibodies. Clin Applied Immunol Rev 2004;4351-66.
28. Burlingame RW, Cervera R. Anti-chromatin (anti-nucleosome) autoantibodies. Autoimmun Rev 2002;1:321-8.
29. Zhao Z, Weinstein E, Tuzova M, Davidson A, Mundel P, Marambio P, et al. Cross-reactivity of human lupus anti-DNA antibodies with α-actinin and nephritogenic potential. Arthritis Rheum 2005;52:522-30.
30. Mostoslavsky G, Fischel R, Yachimovich N, Yarkoni Y, Rosenmann E, Monestier M, et al. Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol 2001;31:1221-7.
31. Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 2004;117:39-50.
32. Csernok E. Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides. Autoimmun Rev 2003;2:158-64.
33. García-Cantón C, Toledo A, Palomar R, Fernandez F, Lopez J, Moreno A, et al. Goodpasture's syndrome treated with mycophenolate mofetil. Nephrol Dial Transplant 2000;15:920-2.
34. Merkel F, Weber M. Successful use of cyclosporin A in progressive anti-glomerular basement membrane nephritis. Nephrol Dial Transplant 2000;15:1714-15.
35. Merkel F, Pullig O, Marx M, Netzer KO, Weber M. Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases. Nephrol Dial Transplant 1994;9:372-6.
36. Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001;134:1033-42.